MedPath

A study of the effects of OSU6162 on chronic fatigue in patients who suffered a mild traumatic brain injury

Phase 1
Conditions
Mental fatigue after traumatic brain injury
Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
Registration Number
EUCTR2011-004990-10-SE
Lead Sponsor
Sahlgrenska Academy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

1. Patients who > 12 months earlier suffered a traumatic brain injury are attended to the Department of Neurorehabilitation, Northern University Hospital.
2. Age 18-65.
Glasgow Outcome Scale (extended), moderate disability (appr 5) or better recovery.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 60
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

1. Significant co-morbidity including psychiatric or neurological disorder.
2. Women of childbearing potential not on contraceptives.
3. Pregnant women.
4. Alcohol or drug abuse.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: Investigate the therapeutic effects of OSU 6162 as measured by self assessment questionnaire, with focus on mental fatigue, recovery and concentration capacity in patients with mental fatigue who suffered a traumatic brain injury.;Secondary Objective: To study the effects of OSU 6162 on objective measures such as neuropsychological testing and functional magnetic resonance imaging, with focus on mental fatigue, and cognitive capacity in patients with mental fatigue who suffered a traumatic brain injury.;Primary end point(s): Investigate the therapeutic effects of OSU 6162 as measured by self assessment questionnaire, with focus on mental fatigue, recovery and concentration capacity in patients with mental fatigue who suffered a traumatic brain injury.
Secondary Outcome Measures
NameTimeMethod
Secondary end point(s): To study the effects of OSU 6162 on objective measures such as neuropsychological testing and functional magnetic resonance imaging, with focus on mental fatigue, and cognitive capacity in patients with mental fatigue who suffered a traumatic brain injury.
© Copyright 2025. All Rights Reserved by MedPath